TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Zim Laboratories Ltd. ( (IN:ZIMLAB) ) is now available.
Zim Laboratories Limited has announced compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This compliance, confirmed by their Registrar and Transfer Agent, MUFG Intime India Private Limited, ensures that securities received for dematerialization have been processed correctly, maintaining the integrity of the company’s listings on stock exchanges.
More about Zim Laboratories Ltd.
Zim Laboratories Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of drug delivery solutions. The company is known for its innovative products and services aimed at enhancing drug efficacy and patient compliance.
Average Trading Volume: 14,800
Technical Sentiment Signal: Sell
Current Market Cap: 3.48B INR
See more insights into ZIMLAB stock on TipRanks’ Stock Analysis page.